|
CSNK2A1P expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.36319999732848E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.71520000214321E-08 |
| Normal-vs-Stage2 |
1.352730E-04 |
| Normal-vs-Stage3 |
1.77240000454049E-08 |
| Normal-vs-Stage4 |
3.10210000020739E-07 |
| Stage1-vs-Stage2 |
7.712800E-01 |
| Stage1-vs-Stage3 |
3.149800E-01 |
| Stage1-vs-Stage4 |
3.041600E-01 |
| Stage2-vs-Stage3 |
3.309400E-01 |
| Stage2-vs-Stage4 |
2.788800E-01 |
| Stage3-vs-Stage4 |
7.983800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.72470002116165E-09 |
| Normal-vs-AfricanAmerican |
1.220060E-02 |
| Normal-vs-Asian |
9.5315000003815E-07 |
| Caucasian-vs-AfricanAmerican |
2.068600E-01 |
| Caucasian-vs-Asian |
5.131800E-01 |
| AfricanAmerican-vs-Asian |
1.202390E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.58890045354588E-10 |
| Normal-vs-Female |
3.1507000008979E-08 |
| Male-vs-Female |
9.500100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.89410000034962E-07 |
| Normal-vs-Age(41-60Yrs) |
1.01479999958798E-08 |
| Normal-vs-Age(61-80Yrs) |
1.20090000055306E-07 |
| Normal-vs-Age(81-100Yrs) |
3.521100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.843600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.408200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.520600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.944200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.159800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.629000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.805580E-01 |
| Classical-VS-Follicular |
1.165210E-01 |
| Classical-VS-Other |
1.816790E-01 |
| Classical-VS-Normal |
1.03980000054626E-07 |
| Tall-VS-Follicular |
7.808800E-01 |
| Tall-VS-Other |
5.071600E-01 |
| Tall-VS-Normal |
1.52996999999155E-05 |
| Follicular-VS-Other |
4.887600E-01 |
| Follicular-VS-Normal |
4.01390000015489E-07 |
| Other-VS-Normal |
2.779500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.19740000931779E-09 |
| Normal-vs-N1 |
1.02620000053122E-07 |
| N0-vs-N1 |
2.324200E-01 |
|
|
